Comparisons
Semaglutide vs retatrutide: what we know so far
How semaglutide and retatrutide compare on mechanism, evidence, availability, and what is actually known about them in 2025.
7 min read · Updated 2026-05-24
Peptide GPS publishes educational information, not medical advice. We don't sell, prescribe, or recommend specific medications, dosages, or providers. Always discuss any therapy with a licensed clinician.
Mechanism
Semaglutide activates one receptor: GLP-1.
Retatrutide activates three: GLP-1, GIP, and glucagon.
Hitting more receptors is not automatically better, but it does explain why the two drugs produce different magnitudes of effect in trials.
Evidence base
Semaglutide has years of large Phase 3 trial data, post-marketing surveillance, and cardiovascular outcome data in real-world populations.
Retatrutide has Phase 2 data and ongoing Phase 3 trials. Long-term safety, durability after stopping, and rare adverse events are still being characterized.
Availability
Semaglutide is FDA-approved and available by prescription (Ozempic, Wegovy, Rybelsus), and at times has been compounded during shortage periods.
Retatrutide is not approved and is not available by prescription. Anything sold online under that name is unregulated.
Why this comparison is harder than it looks
Comparing average weight loss percentages across trials with different designs, populations, and durations is a common source of misleading headlines.
Side effect profiles also differ — the addition of glucagon agonism in retatrutide may have effects that single-receptor GLP-1 drugs do not.
Until head-to-head trials report, statements about which is ''more effective'' or ''safer'' for a given person are claims, not conclusions.
Key takeaways
- Different mechanisms (single vs triple agonist) and very different evidence bases.
- Semaglutide is approved and prescribed; retatrutide is investigational.
- Cross-trial comparisons are not the same as head-to-head evidence.
Get the weekly brief
One plain-English email per week on GLP-1s, peptides, and the regulation around them.